101730.KQ Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
00:41
May 28
May 28
Obesity drug data very strong.
DND Pharmatech released strong 48-week phase 2 data for its obesity drug DD01, which drove a limit-up and continued rally, signaling significant pipeline value.
MED
About 101730.KQ Analyst Coverage
Buzzberg tracks 101730.KQ across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.